bioRxivCancer BiologyPreprint
Pervasive chromothripsis drives pleural mesothelioma to impact gene function and patient survival
Colin SempleiD, Kitty Sherwood, Stuart AitkeniD, Ryan Silk, Mihail Halachev, Stephen Fox, Devin Bendixsen, Alhafidz Hamdan, Kevin G Blyth
Abstract
Pleural mesothelioma (PM) is a tumour type showing high structural complexity but the full spectrum of variants present and their impacts are poorly understood. We comprehensively describe the mutational landscape of mesothelioma, exploiting a large (N=443) cohort profiling the tumour genome and transcriptome in parallel. We find that the majority of candidate driver variants are mediated by copy number alterations (CNAs) and discover high frequencies of complex rearrangements across most tumours, dominated by chromothripsis (74% of tumours) and chromoplexy (59%). Chromothripsis contributes to significant CNA hotspots to delete known PM tumour suppressor genes such as CDKN2A, NF2 and BAP1, thought to be among the earliest events in PM development; and the presence of chromothripsis is associated with significantly worse patient survival. We also discover multi-faceted crosstalk between the mitochondrial and nuclear genomes during PM evolution, involving alterations to both genomes, and mitochondrial expression changes associated with subtypes and chromothripsis.
- organism: human
- assay: whole-genome sequencing
- assay: bulk RNA-seq
- research focus: chromatin & epigenetic regulation
- research focus: cancer & tumor microenvironment
- research focus: differential expression
- approach: statistical model
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Gene fusions during the early evolution of mesothelioma correlate with impaired DNA repair and Hippo pathways
Maymun Jama, Min Zhang, … Edward J. Hollox·Genes Chromosomes and CancerPeer-reviewed·Jul 8, 2023
- Well-Differentiated Papillary Mesothelioma of the Peritoneum is Genetically Distinct from Malignant Mesothelioma
R. Shrestha, N. Nabavi, … A. Churg·bioRxiv·Jul 23, 2019
- Disentangling heterogeneity of Malignant Pleural Mesothelioma through deep integrative omics analyses
L. Mangiante, N. Alcala, … Meyer·bioRxiv·Sep 27, 2021
- Single cell multi-omics analysis of chromothriptic medulloblastoma highlights genomic and transcriptomic consequences of genome instability
R. G. Parra, M. J. Przybilla, … A. Ernst·bioRxiv·Jun 25, 2021
- Rare Germline Variants and Genetic Susceptibility to Pleural Mesothelioma: Moving Beyond DNA Repair
Elton Jalis Herman, Carla Debernardi, … Giuseppe Matullo·medRxiv·Oct 2, 2026
- A molecular phenotypic map of Malignant Pleural Mesothelioma
Alex Di Genova, Lise Mangiante, … Matthieu Foll·GigaSciencePeer-reviewed·Dec 28, 2022